PUNE, India, May 30, 2017 /PRNewswire/ --
According to a new market research report "Microbiome Sequencing Services Market Technology (Sequencing by Synthesis), Application (RNA Sequencing), Research Type (Outsourcing), Laboratory Type (Wet Lab, Dry Lab), End User (Pharmaceutical & Biotechnology), Other Technologies - Forecast to 2021" published by MarketsandMarkets™, the global microbiome sequencing services market is poised to reach USD 1424.7 Million by 2021 from USD 538.0 Million in 2016, at a CAGR of 21.5% from 2016 to 2021.
Browse 44 market data tables and 27 figures spread through 121 pages and in-depth TOC on "Microbiome Sequencing Services Market"
Early buyers will receive 10% customization on this report.
Microbiome Sequencing Services Market Report provides a detailed overview of the major drivers, restraints, and threat impacting the high-resolution melting analysis market along with the estimates and forecasts of the revenue and market share analysis.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=94324380
Major factors fueling market growth are the rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS). On the other hand, lack of detailed research, government regulations, and ethical and legal issues related to NGS are the major factors restraining the growth of microbiome sequencing services market.
The global microbiome sequencing services market is segmented on the basis of technology, application, research type, laboratory type, end user, and region.
By technology, the market is divided into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and other technologies (such as Omic technologies). The sequencing by synthesis segment is expected to grow at the highest CAGR in the market in 2016. This growth rate can be attributed to the prevalent high demand for this technology.
Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and other applications (such as small molecule analysis and protein analysis). The shotgun sequencing segment is estimated to grow at the highest CAGR during the forecast period.
Based on research type, the market is divided into internal research and outsourced research. The outsourced research segment is expected to command the fastest CAGR in the market in 2016. This largest share and fastest CAGR is primarily due to increase in outsourced R&D services, as they are less expensive.
On the basis of laboratory type, the market is broadly divided into wet labs and dry labs. The wet labs research segment is expected to command the highest CAGR in the market in 2016.
Based on end user, the market is broadly divided into pharmaceutical and biotechnology companies and academic/research institutes. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR in the market in 2016.
Talk to our Research Expert @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=94324380
North America is expected to be at the highest CAGR in the global microbiome sequencing services market in 2016. Factors such as favorable business environment, government support through funds for genomics research, continuous developments in sequencing technologies, availability of commercial solutions for NGS data analysis, growing number of research studies on cancer & inherited rare diseases drive the growth of the market in this region.
Browse Related Reports:
Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Visit Our Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets